Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA)

Competitors to Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA)

Amyris, Inc.

Amyris focuses on producing sustainable ingredients through synthetic biology, similar to Ginkgo Bioworks. Their competition lies in the ability to create high-performance, eco-friendly products for cosmetics, food, and health industries. While both companies emphasize sustainability, Amyris has a stronger brand recognition in consumer markets due to its established products, which gives it an edge over Ginkgo in certain consumer-facing segments, although Ginkgo's broader platform capabilities may provide it with longer-term growth potential.

Arzeda

Arzeda specializes in protein engineering and has developed a platform for designing novel enzymes for various applications, such as industrial biocatalysis and biomanufacturing. In competing with Ginkgo Bioworks, Arzeda differentiates by focusing heavily on computational protein design and efficiency in enzyme performance. However, Ginkgo's larger scale and more diverse project portfolio provide it with a significant competitive advantage, allowing it to engage with a broader market across different sectors.

Synlogic 

Synlogic focuses on the development of living medicines, utilizing synthetic biology to create engineered probiotics for therapeutic applications. While Ginkgo Bioworks also explores therapeutic applications through its platform, Synlogic's concentration on disease-modifying therapies offers a niche competitive angle. However, Ginkgo's larger resource pool and collaborations provide it with a comprehensive bioengineering platform that allows them to tackle a wider range of applications, thus giving them the competitive upper hand.

Zymergen

Zymergen and Ginkgo Bioworks operate in the synthetic biology space, leveraging advanced technology to optimize biological systems for a range of industries, including pharmaceuticals, agriculture, and materials. Both companies use high-throughput automation and machine learning to streamline the development process of bio-based products. However, Ginkgo Bioworks holds a competitive advantage due to its extensive partnerships and established customer base, which enhances its revenue-generating capabilities more effectively than Zymergen.